Hindustan TimesAntidepressant fluvoxamine may reduce risk of Covid-19 hospitalisation: StudyOct 28, 2021Zarafshan ShirazBy Zarafshan Shirazmore_vert
The Wall Street JournalAntidepressant Fluvoxamine Significantly Reduces Covid-19 HospitalizationOct 28, 2021Sarah ToyBy Sarah Toymore_vert
The Washington PostAntidepressant fluvoxamine shows promise as coronavirus treatment, scientists sayOct 28, 2021Marisa Iati & Adela SulimanBy Marisa Iati & Adela Sulimanmore_vert
CNNCheap, generic anti-depressant may reduce severe Covid-19 disease, study findsOct 28, 2021Maggie FoxBy Maggie Foxmore_vert
Science News MagazineThe antidepressant fluvoxamine can reduce COVID-19 hospitalizationsOct 27, 2021Esther LandhuisBy Esther Landhuismore_vert
Full CoverageFull Coverage
